Boston Business Journal Report: Multiple Sclerosis Drug Producer Grows

A Massachusetts-based biotech unit acheived huge revenue growth last year.

Boston Business Journal BioFlash editor Don Seiffert joins necn to discuss his story, "​Sanofi Genzyme revenues grow 30% in 2015 to top $4B."

Click here to read the full report.

Contact Us